Search
PAVmed Inc
PAVMAdd to Watchlist
5.710USD
-0.540-8.57%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
35.80MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of PAVmed Inc is 8.00, ranking 67 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 12.00, with a high of 20.00 and a low of 4.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
36.000
Target Price
+471.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
3
Median
6
Average
Company name
Ratings
Analysts
PAVmed Inc
PAVM
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is PAVmed Inc's expected revenue for the next quarter?
PAVmed Inc's expected revenue is 98.00K.
What is PAVmed Inc's price target?
Analysts forecast that PAVmed Inc's price target is USD 12.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 4.00.
How have PAVmed IncPAVM's recent earnings per share performed?
The market expectation was USD -4.42, while PAVmed IncPAVM's earnings per share (EPS) for the previous quarter was USD -2.05. EPS for the next quarter is expected at USD -0.47.
What is the analyst rating for PAVmed Inc?
Based on the ratings of PAVmed Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.